While not perfect, vaccinations are the best bet for avoiding a bad case of flu or COVID-19 this fall and winter. The CDC ...
In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV ...
Overall, 55.8% of infants were protected by either maternal RSV vaccination, nirsevimab, or both; 14.2% of infants were ...
Survey reveals gaps in vaccination intentions for flu, COVID-19, respiratory syncytial virus, and pneumococcal disease.
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of RSV in 2021, according to a ...
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
Poynter has partnered with the Risk Less. Do More. campaign to host a webinar, articles to better inform journalists.
The 2024-25 respiratory season is underway and for the first time, New Brunswick will offer some seniors immunization against ...
The American Lung Association is launching a new campaign aimed at boosting RSV vaccine rates. Health experts say nearly 80,000 children up to five years old are hospitalized each year with RSV.